Recent Finacing
Recent Raise
Epic Sciences operates a CAP/CLIA‑accredited laboratory developing blood‑based liquid biopsies that combine circulating tumor cell imaging and cell‑free DNA sequencing for multi‑omic cancer profiling and decision support to pharma.